DSIP (Delta-Sleep-Inducing Peptide) Laboratory Research Guide

DSIP (Delta-Sleep-Inducing Peptide) is a nonapeptide extensively researched for delta-wave sleep induction, neuroendocrine regulation, and stress-axis modulation. PX1 Research supplies USA-manufactured DSIP at verified purity levels exceeding 99%, backed by lot-specific third-party COAs featuring RP-HPLC, mass spectrometry, and endotoxin analysis. All orders ship same-day M–F from California and Arizona facilities.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

DSIP (Delta-Sleep-Inducing Peptide) is a nonapeptide extensively researched for delta-wave sleep induction, neuroendocrine regulation, and stress-axis modulation. PX1 Research supplies USA-manufactured DSIP at verified purity levels exceeding 99%, backed by lot-specific third-party COAs featuring RP-HPLC, mass spectrometry, and endotoxin analysis. All orders ship same-day M–F from California and Arizona facilities.

Reviewed by PX1 Research scientific team

Key takeaways

  • Delta-Sleep-Inducing Peptide (DSIP) is an endogenous nonapeptide (sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) originally isolated from the cerebral venous blood of rabbits induced into slow-wave sleep.
  • DSIP was first isolated in 1977 by Schoenenberger and Monnier in Basel, Switzerland.
  • Preclinical studies indicate that DSIP exerts its primary physiological actions through modulation of central neurotransmitter systems and endocrine feedback loops.
  • In multi-peptide research protocols, investigators frequently evaluate DSIP alongside complementary neuroendocrine and restorative peptides to examine synergistic mechanisms in cellular or animal models.

At a glance: The short version of DSIP research

Delta-Sleep-Inducing Peptide (DSIP) is an endogenous nonapeptide (sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) originally isolated from the cerebral venous blood of rabbits induced into slow-wave sleep. In preclinical literature, DSIP is primarily evaluated for its capacity to initiate slow-wave (delta-wave) EEG rhythms, alter central neurochemistry, and modulate hypophyseal-pituitary-adrenal (HPA) stress axis activity without causing heavy central nervous system depression.

Unlike conventional sedative compounds, DSIP functions as a regulatory peptide rather than a direct pharmacological CNS depressant. In laboratory models, administration of DSIP leads to normalized sleep architecture, enhanced recovery markers during rest periods, and attenuation of excessive corticotropin secretion under physiological stress. Researchers sourcing DSIP for in vitro assays or preclinical animal models require verified analytical standards to ensure exact sequence identity and absence of bacterial endotoxins.

To review physical specifications, analytical data, or to order 5 mg vials of DSIP, researchers can query the live inventory in the PX1 Research peptide catalog.

What is DSIP and how was it discovered?

DSIP was first isolated in 1977 by Schoenenberger and Monnier in Basel, Switzerland. The research team identified a circulating humoral factor capable of inducing slow-wave sleep in recipient subjects during electrical stimulation of the thalamus. Structural analysis identified the compound as a free nonapeptide with a molecular weight of 848.81 g/mol.

Subsequent investigations revealed that DSIP exists in both free and bound forms throughout central and peripheral tissues, including the hypothalamus, limbic structures, pituitary gland, and human plasma. Because the peptide readily crosses the blood-brain barrier via passive diffusion and specific transport mechanisms, it has served as a key model compound for studying central sleep regulation, circadian entrainment, and neuroendocrine signaling.

What is the preclinical mechanism of action for DSIP?

Preclinical studies indicate that DSIP exerts its primary physiological actions through modulation of central neurotransmitter systems and endocrine feedback loops. Rather than binding exclusively to a single classic receptor, DSIP exhibits multi-target regulatory signaling across several pathways:

1. Delta-Wave Induction: Electrophysiological recordings in rodent and non-human primate models demonstrate that DSIP administration increases the duration and amplitude of low-frequency delta waves (0.5–4 Hz) on electroencephalography (EEG), characteristic of Stage N3 non-REM sleep.

2. HPA Axis and Stress Modulation: DSIP suppresses excessive release of adrenocorticotropic hormone (ACTH) and baseline corticosterone/cortisol elevation induced by environmental stress. It modulates the central release of corticotropin-releasing factor (CRF), protecting biological systems from stress-induced physiological degradation.

3. Neurotransmitter Balance: In vitro brain slice preparations demonstrate that DSIP influences monoamine oxidase activity, modulates serotinergic transmission in the raphe nuclei, and enhances GABAergic inhibitory tone without downregulating receptor expression.

4. Endocrine Regulation: Beyond sleep-wake cycles, research links DSIP modulation to basal luteinizing hormone (LH) and somatotropin (growth hormone) pulse amplitude maintenance during rest periods.

Which peptides DSIP interact with in laboratory models?

In multi-peptide research protocols, investigators frequently evaluate DSIP alongside complementary neuroendocrine and restorative peptides to examine synergistic mechanisms in cellular or animal models.

For example, researchers studying circadian biology and longevity markers often cross-reference DSIP data with the Epitalon research guide, examining how pineal peptide balance influences systemic aging markers. Similarly, experiments focused on anxiolytic neurochemistry combined with sleep structure frequently incorporate the Selank research profile alongside DSIP to measure concurrent GABAergic and serotonergic modulation.

When studying somatotrophic signaling during sleep cycles, investigators often evaluate DSIP alongside growth hormone secretagogues such as CJC-1295 No DAC or Ipamorelin. For a complete overview of available comparative reagents, explore the broader research peptide library.

Laboratory criteria for evaluating DSIP quality and suppliers

Because synthetic nonapeptides are susceptible to truncated peptide impurities, trifluoroacetate (TFA) salt accumulation, and endotoxin contamination during solid-phase peptide synthesis (SPPS), research facilities must maintain rigorous vendor evaluation criteria.

To ensure experimental reproducibility, verified research reagents must fulfill the following laboratory criteria prior to purchase:

• Purity Verification: Minimum 99% chemical purity confirmed via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC). Peak area integration must show no significant truncated sequences.

• Mass Verification: Electrospray Ionization Mass Spectrometry (ESI-MS) confirming exact monoisotopic mass (848.81 Da ± 0.5 Da).

Endotoxin Testing: Quantitative Chromogenic LAL (Limulus Amebocyte Lysate) assay confirming endotoxin levels below 0.01 EU/mg to eliminate inflammatory signaling artifacts in cell assays.

• Domestic Synthesis & Quality Control: Manufactured in compliance with cGMP standards within US facilities to ensure lot-to-lot consistency.

• Transparent Lot Traceability: Direct access to downloadable batch-specific Certificates of Analysis (COAs) matching the physical vial lot number.

• Rapid Cold-Chain Handling & Shipping: Immediate same-day dispatch with temperature-monitored domestic delivery to prevent thermal degradation during transit.

Red flags to avoid when sourcing DSIP peptides online

Navigating the research chemical marketplace requires identifying vendor practices that compromise sample integrity or signal non-compliant operations. Researchers should reject suppliers exhibiting any of the following red flags:

1. Missing or Generic COAs: Vendors supplying generic laboratory reports without batch numbers, date stamps, or explicit HPLC chromatograms should be disqualified.

2. Human Dosing or Clinical Claims: Any vendor offering dosage calculators, reconstitution guidelines for human injection, or therapeutic claims is operating outside regulatory compliance for laboratory reagents.

3. Unverified Foreign Reselling: Suppliers drop-shipping unanalyzed bulk powders directly from overseas factories frequently deliver sub-purity batches contaminated with synthesis side-products or heavy metals.

4. Lack of Endotoxin Verification: Peptides intended for cell culture or preclinical animal models that lack LAL endotoxin testing can induce acute neuroinflammatory responses, invalidating study outcomes.

When sourcing high-purity nonapeptides, researchers can safely buy DSIP online directly from verified US facilities through PX1 Research.

Handling, reconstitution, and storage protocols for DSIP vials

DSIP is supplied as a lyophilized (freeze-dried) cake inside sealed glass vials under vacuum. Maintaining structural integrity during storage, reconstitution, and pipetting is essential for protocol accuracy.

Lyophilized Storage: Upon receipt, store intact, sealed vials of lyophilized DSIP at -20°C for short-term preservation or -80°C for long-term storage (up to 24 months). Protect vials from direct light exposure.

Reconstitution Protocol: Allow lyophilized vials to equilibrate to room temperature before reconstitution to prevent moisture condensation. Using aseptic technique, reconstitute the powder using Bacteriostatic Water (0.9% benzyl alcohol) or Sterile Reconstitution Solution. Direct the liquid down the inner glass wall of the vial rather than shooting directly onto the peptide cake. Gently swirl the vial until fully dissolved; never vortex high-purity peptides as mechanical shear force can disrupt tertiary structures.

Post-Reconstitution Storage: Reconstituted liquid DSIP solution should be aliquoted into single-use polypropylene microtubes to prevent repeated freeze-thaw cycles and stored at 2°C to 8°C. Liquid solutions remain stable for up to 30 days under refrigeration, or up to 6 months when frozen at -80°C.

Comparative analysis: DSIP vs. other research peptides for sleep and recovery

Understanding how DSIP differs structurally and functionally from other research molecules helps investigators select the correct research candidate for their experimental models.

While DSIP targets non-REM delta-wave sleep induction and HPA-axis regulation, compounds like BPC-157 research peptide focus on tissue repair cascades, angiogenic pathways, and gastrointestinal protection. Researchers studying systemic cellular protection often examine both signaling cascades in combined stress-recovery models.

Similarly, while central neuropeptides like Semax peptide research stimulate neurotrophic factor expression (BDNF/NGF) and enhance alertness during active waking cycles, DSIP operates during the rest state to restore physiological homeostasis and regulate basal stress responses.

Ordering DSIP from PX1 Research

PX1 Research provides verified, analytical-grade DSIP designed specifically for stringent laboratory research workflows. Every lot undergoes complete physical and chemical validation prior to distribution.

What Ships: High-purity DSIP nonapeptide provided as a sterile, vacuum-sealed lyophilized cake in 5 mg glass vials. Each vial features a tamper-evident seal and batch lot code linked directly to its analytical report.

Dispatch & Logistics: Orders placed before 3:00 PM EST Monday through Friday ship same-day from our primary fulfillment centers in California and Arizona. Shipments are packed in protective cold-insulating materials and shipped via tracked domestic transit (USPS Priority or FedEx Express).

Analytical Assurance: Researchers can instantly view and download lot-specific RP-HPLC chromatograms, mass spectrometry reports, and endotoxin assay data by entering their lot number at checkout or on our analytical database.

Customer Support: Technical support is staffed by research specialists available via email and phone to answer analytical, storage, or supply chain questions. For institutional procurement or high-volume inquiries, submit a request through our bulk peptide purchasing portal.

Ready to advance your neuropeptide studies? Select your quantity and order 10 mg vials of Retatrutide or order 5 mg vials of DSIP today.

Frequently Asked Questions

dsip

DSIP (Delta-Sleep-Inducing Peptide) is a naturally occurring nonapeptide evaluated in preclinical research for inducing delta-wave slow-wave sleep, modulating the hypophyseal-pituitary-adrenal (HPA) stress axis, and balancing central neurochemistry. PX1 Research supplies high-purity DSIP manufactured in the USA with lot-specific RP-HPLC and mass spec analysis.

peptides dsip

Peptides like DSIP belong to a class of regulatory neuropeptides that cross the blood-brain barrier to influence sleep architecture and stress responses. In laboratory models, DSIP is studied for its non-depressant action in stabilizing slow-wave sleep and controlling corticotropin secretion under stress.

What is the primary mechanism of DSIP in research models?

Preclinical studies show DSIP enhances non-REM delta-wave activity (0.5–4 Hz) on EEG, reduces excessive ACTH release from the pituitary gland, and modulates GABAergic and serotonergic neurotransmission in the central nervous system without causing classic sedative dependence.

What purity level is PX1 Research DSIP?

PX1 Research guarantees DSIP at >99% purity verified by independent Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Electrospray Ionization Mass Spectrometry (ESI-MS). Every lot also undergoes chromogenic LAL endotoxin testing.

Do you provide a COA for my DSIP lot?

Yes. Every single shipment of DSIP from PX1 Research includes batch-specific analytical documentation showing full HPLC chromatograms, mass spectrometry verification, purity percentages, and endotoxin assay scores accessible directly online.

How fast does PX1 ship DSIP orders?

Orders placed before 3:00 PM EST, Monday through Friday, ship same-day from our California or Arizona fulfillment centers. All orders include expedited tracked domestic shipping.

Is DSIP legal to buy in the US?

Yes, DSIP is legal to purchase in the United States as a laboratory research chemical. It is strictly designated for in vitro, biochemical, and preclinical laboratory research and is not approved for human or veterinary use.

How should lyophilized DSIP be stored upon arrival?

Lyophilized DSIP should be stored at -20°C for short-term preservation or -80°C for long-term stability, protected from direct light. Reconstituted solutions should be refrigerated at 2°C to 8°C and used within 30 days.

Can DSIP be ordered in bulk for institutional research?

Yes. PX1 Research accommodates institutional procurement and bulk inquiries with volume pricing and dedicated quality control support through our bulk ordering program.

Related pages

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.